Do you provide Pigmentation & Melanogenesis?
How Pigmentation & Melanogenesis testing maps the melanin pathway
Melanin is made inside melanosomes in melanocytes, then handed through dendrites to the surrounding keratinocytes. Each child service in this group measures one part of that chain, so an active can be placed at the stage where it works.
Enzyme and gene expression assays
Tyrosinase inhibition screens use mushroom or human tyrosinase with L-DOPA or L-tyrosine and read dopachrome formation by absorbance. They rank many candidates quickly and give IC50 values. Tyrosinase activity, MITF regulation and TRP1/TRP2 modulation move into cells, where qPCR, western blot or ELISA measure the transcription factor and the melanogenic proteins TYRP1 and DCT. Alpha-MSH pathway regulation tests whether an active alters the MC1R and cAMP signal that switches melanogenesis on.
Melanocyte and transfer models
Melanocyte activity studies use primary human melanocytes or B16 murine cells and report melanin content normalised to protein, with viability run in parallel. Dendritic process reduction quantifies dendrite number and length by microscopy. Pigment vesicle dynamics follows melanosome maturation and transport, and pigment transfer inhibition uses melanocyte and keratinocyte co-cultures or pigmented reconstructed epidermis with Fontana-Masson staining and image analysis.
Lightening and darkening studies
Depigmentation testing looks for lower melanin output. Pro-pigmentation testing looks for higher output, for self-tan boosters, grey hair research or actives that support an even tan. Both draw on the same assays with different reference compounds as positive controls.
Data package from the laboratory
A report with the model, concentrations, controls, raw and normalised data, dose-response curves and statistics, plus images for the microscopy endpoints.
Services in Pigmentation & Melanogenesis
Choosing a Pigmentation & Melanogenesis study for your active
The right assay depends on where your active is expected to act and how far along development you are.
Start with the claim you want to make
A cell-free tyrosinase screen suits early triage of a botanical extract library, because it is quick and needs little material. Once you have two or three leads, move to melanocytes to confirm a fall in melanin content at non-toxic doses. If your active is meant to work downstream of melanin synthesis, as niacinamide-type actives are thought to do, the transfer and dendricity assays are where the effect will show.
Building a mechanism package
Ingredient suppliers often combine one enzyme assay, one expression readout such as MITF or TRP1 and one cell or tissue model. That set gives coherent mechanism evidence for a technical data sheet. Running the same doses across all three lets the results be read together.
Taking the active to human skin
When a lead is chosen and formulated, the next step is a volunteer study. Dark-spot and skin-tone efficacy testing measures spot contrast and tone evenness during product use, and the in vitro data helps you choose its dose and comparator.
What to send for a quote
Prepare the test material with its solvent and solubility, the concentration range you expect to use, the direction of effect sought and any reference active you want included. Ask the laboratory which tyrosinase source and cell line it uses, since mushroom and human enzymes rank inhibitors differently.
More in Pigmentation Radiance Testing
Skin pigmentation, dark spot and radiance testing measures spots, tone and glow on volunteers, and pigment production in melanocyte models.


